February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.
These guidelines represent a comprehensive update to the 2014 recommendations, developed following a thorough literature review and consensus among experts from the three major GI societies.
Randomized trial shows twice-daily supplementation improves quality of life, reduces inflammation markers, and lessens symptom severity in patients with mild to moderate disease.
Researchers found that children with functional gastrointestinal disorders experience higher school absenteeism than those with organic diseases, suggesting absenteeism could provide diagnostic insight.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"These differences were largely driven by the high rate of adverse events leading to study discontinuation in the OIT-treated participants, despite receiving omalizumab treatment at the initiation of therapy."
Researchers found that most social media posts promoting medical tests with potential for overdiagnosis predominantly focused on benefits, with limited discussion of harms or supporting scientific evidence.
The finalization of new criteria for the "healthy" nutrient content claim on food labels has been delayed, allowing more time for regulatory review of standards that could significantly influence labeling practices and help reduce diet-related chronic diseases.